etoposide has been researched along with Gestational Trophoblastic Neoplasia in 98 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 33 (33.67) | 29.6817 |
2010's | 51 (52.04) | 24.3611 |
2020's | 14 (14.29) | 2.80 |
Authors | Studies |
---|---|
Feng, F; Ji, M; Jiang, S; Ren, T; Wan, X; Xiang, Y; Yang, J; Zhao, J | 1 |
Chatterjee, T; Lindahl, L; Martial, A; Settypalli, S | 1 |
Berkowitz, RS; Braga, A; Elias, KM; Freitas, F; Fülöp, V; Horowitz, NS; Jareemit, N; Maestá, I; Paiva, G; Ramírez, LAC; Therasakvichya, S | 1 |
Gillett, S; Hapuarachi, B; Ireson, J; Romanowski, C; Singh, K; Tidy, JA; Winter, MC | 1 |
Baloch, SS; Khan, SR; Moosajee, M; Samon, Z; Shahid, A; Shahzadi, M; Tariq, M | 1 |
Ino, K; Kajiyama, H; Kikkawa, F; Kotani, T; Niimi, K; Nishino, K; Sato, S; Suzuki, S; Yamamoto, E | 1 |
Chang, WH; Cheng, NM; Wang, PH | 1 |
Cheng, M; Lee, NR; Wang, PH | 1 |
Berkowitz, RS; Elias, KM; Goldstein, DP; Horowitz, NS; Jareemit, N | 1 |
Qian, XQ; Shen, YM; Wan, XY; Xie, X | 1 |
Coleman, RE; Gillett, S; Hancock, BW; Hills, A; Ireson, J; Singh, K; Tidy, JA; Winter, MC | 1 |
Chen, Y; Wang, K | 1 |
Braga, A; Mattar, R; Passos, JP; Signorini Filho, RC; Silva, ACBD; Sun, SY | 1 |
Allias Montmayeur, F; Bolze, PA; Descargues, P; Devouassoux-Shisheboran, M; Golfier, F; Hajri, T; Lotz, JP; Massardier, J; You, B | 1 |
Duan, W; Kong, W; Miao, J; Shen, L; Su, L; Wang, M; Wu, Y; Xu, X | 1 |
Feng, F; Kong, Y; Li, Y; Ren, T; Wan, X; Xiang, Y; Yang, J; Zhao, J | 1 |
Eysbouts, YK; IntHout, J; Lok, CAR; Massuger, LFAG; Ottevanger, PB; Sweep, FCGJ | 1 |
Feng, F; Jiang, F; Kong, Y; Li, J; Ren, T; Wan, X; Wang, X; Xiang, Y; Yang, J; Zhao, J | 1 |
Brown, J; Bruegl, A; Essel, KG; Gershenson, DM; Naumann, RW; Ramondetta, LM | 1 |
Bergamini, A; Candiani, M; Cioffi, R; Cormio, G; Gadducci, A; Giorgione, V; Mangili, G; Pella, F; Petrone, M; Rabaiotti, E | 1 |
Berry, E; Hoekstra, AV; Lurain, JR; Maniar, KP; Novak, K; Sobecki-Rausch, J; Winder, A | 1 |
Harada, N; Haruta, N; Higashiura, Y; Hisanaga, H; Nobuhara, I; Sado, T; Watanabe, H; Watanabe, S | 1 |
Akizawa, Y; Kanno, T; Matsui, H; Shozu, M; Usui, H | 1 |
Huang, XF; Liu, W; Zhang, YQ; Zhao, W | 1 |
Coulter, J; Frijstein, MM; Golfier, F; Lok, CAR; Massuger, LFAG; Seckl, MJ; Ten Kate-Booij, MJ; van Trommel, NE | 1 |
Berkowitz, RS; Braga, A; Dos Santos Esteves, APV; Elias, KM; Filho, JR; Horowitz, NS; Mora, PAR; Sun, SY; Uberti, EH; Velarde, GC | 1 |
Benigno, BB | 1 |
Bajpai, J; Deodhar, K; Gulia, S; Gupta, S; Kerkar, RA; Maheshwari, A; Menon, S; Rekhi, B; Seth, V | 1 |
Augereau, P; Balleyguier, C; Droz, JP; Duvillard, P; Even, C; Fizazi, K; Floquet, A; Kerbrat, P; Leary, A; Lhommé, C; Morice, P; Pautier, P; Rey, A; Tazi, Y; Troalen, F | 1 |
Feng, FZ; Ren, T; Wan, XR; Wang, T; Xiang, Y | 1 |
Ahmad, S; Ahmed, M; Al-Badawi, IA; Al-Hashem, H; Al-Hayli, S; Al-Husaini, H; Darwish, A; Edesa, W; Elghamry, W; Elhassan, T; Eltigani, A; Madkhali, I; Omar, A; Soudy, H | 1 |
Gilani, MM; Khorasanizadeh, F; Mousavi, AS; Zamani, A; Zendehdel, K | 1 |
Camarata, M; Cooke, R; Dancy, G; Krell, J; Kwan, A; O'Nions, J; Savage, P; Seckl, MJ; Short, D; Swerdlow, A | 1 |
Kelpanides, I; Savage, P; Seckl, MJ; Short, D; Tuthill, M | 1 |
Berkowitz, RS; Bernstein, MR; Goldstein, DP; Horowitz, NS; Maestá, I; Moulder, J; Ramírez, LA | 1 |
Feng, F; Ren, T; Wan, X; Xiang, Y; Xiao, C; Yang, J; Zhao, J | 1 |
Berkowitz, RS; Bernstein, MR; Goldstein, DP; Horowitz, NS; Maestá, I; Ramírez, LA | 1 |
Faaborg, L; Hansen, ES; Lindegaard, JC; Niemann, I; Ostenfeld, EB; Sunde, L | 1 |
Boonyapipat, S; Rattanaburi, A; Supasinth, Y | 1 |
Abdi, S; Coleman, RE; Hancock, BW; Lo, C; Price, JM; Tidy, J; Winter, MC | 1 |
Cosio, S; Gadducci, A; Lanfredini, N | 1 |
Bolze, PA; Golfier, F; Hajri, T; Lotz, JP; Massardier, J; Riedl, C; Schott, AM; You, B | 1 |
Hu, T; Shi, Y; Song, SQ; Wang, C; Xu, SQ; Yang, ZR; Zhang, GN; Zhu, Y | 1 |
Bae, SN; Byun, SW; Park, TC | 1 |
Nevado-Gammad, MS; Soriano-Estrella, AL | 1 |
Cosio, S; Fanucchi, A; Gadducci, A; Manacorda, S; Pistolesi, S; Strigini, FL; Tana, R | 1 |
Feng, F; Ren, T; Wan, X; Xiang, Y; Yang, J | 1 |
Berkowitz, RS; Braga, A; Burlá, M; Elias, KM; Lin, L; Madi, JM; Maestá, I; Sun, SY; Torres, B; Uberti, E; Viggiano, M | 1 |
Berkowitz, RS; Fülöp, V; Szepesi, J; Szigetvŕi, I; Török, M | 1 |
Behnamfar, F; Mousavi, SA | 1 |
Cao, Y; Feng, FZ; Li, L; Wan, XR; Xiang, Y; Yang, XY | 1 |
Belfort, P; Braga, A; Consonni, M; Delmanto, LR; Maestá, I; Michelin, OC; Rudge, MV | 1 |
Cao, Y; Feng, FZ; Wan, XR; Xiang, Y; Yang, XY | 1 |
Anderson, ML; Beasley, AD; Coleman, NM; Kolomeyevskaya, NV; Miller, HJ; Tanyi, JL | 1 |
Cao, Y; Feng, F; Wan, X; Xiang, Y; Yang, X | 1 |
Cao, Y; Feng, F; Xiang, Y | 1 |
Cho, YL; Choi, MH; Hong, DG; Lee, YS; Park, IS | 1 |
Antsaklis, A; Belitsos, P; Chatzinikolaou, I; Dimopoulos, AM; Papadimitriou, CA; Rodolakis, A; Thomakos, N; Zagouri, F | 1 |
Feng, FZ; Wan, XR; Xiang, Y; Zhou, Y | 1 |
Feng, F; Geng, S; Wan, X; Wang, T; Xiang, Y | 1 |
Harvey, R; Mitchell, H; Savage, P; Schmid, P; Seckl, M; White, S | 1 |
Cyriac, S; Rajendranath, R; Sagar, TG; Sridevi, V | 1 |
Cole, LA | 1 |
Aydiner, A; Bengisu, E; Berkman, S; Ilhan, HR; Keskin, S; Tas, F; Topuz, E | 1 |
Amant, F; Devi, UK; Han, SN; Leunen, K; Neven, P; Vergote, I | 1 |
Amant, F; Berteloot, P; Devi, UK; Han, SN; Leunen, K; Neven, P; Vergote, I | 1 |
Lybol, C; Massuger, LFAG; Ottevanger, PB; Sweep, FCGJ; Thomas, CMG; Westerdijk, K | 1 |
Baptista, AM; Belfort, P | 1 |
Centen, DW; Lybol, C; Massuger, LF; Ottevanger, PB; Sweep, FC; ten Kate-Booij, MJ; Thomas, CM; Verheijen, RH | 1 |
Blanken, EA; Boere, IA; Lybol, C; Massuger, LF; Ottevanger, PB; Reyners, AK; Sweep, FC; Thomas, CM; van Hoesel, RQ; Verheijen, RH; Westermann, AM | 1 |
Song, SQ; Zhang, GN | 1 |
Agarwal, R; Alifrangis, C; Fisher, RA; Harvey, R; Savage, PM; Sebire, NJ; Seckl, MJ; Short, D | 1 |
Goto, M; Hirokawa, W; Iwase, A; Kikkawa, F; Kondo, M; Nakahara, T; Nakamura, T; Sugita, A; Takikawa, S; Yamamoto, E | 1 |
Au, WY; Chim, CS; Chung, LP; Kwong, YL; Ma, SK | 1 |
Iitsuka, Y; Matsui, H; Seki, K; Sekiya, S; Suzuka, K; Tanaka, N; Yamazawa, K | 1 |
Bozorgi, K; Escobar, PF; Fishman, DA; Lurain, JR; Singh, DK | 1 |
Markman, M | 1 |
Behtash, N; Ghaemmaghami, F; Hanjani, P; Soleimani, K | 1 |
Iitsuka, Y; Matsui, H; Mitsuhashi, A; Sekiya, S; Suzuka, K; Yamazawa, K | 1 |
Sun, Z; Wan, X; Xiang, Y; Yang, X | 1 |
Covens, A; Gerulath, A; Merchandani, DE; Mirchandani, D; Osborne, R | 1 |
Matsui, H; Mitsuhashi, A; Seki, K; Sekiya, S; Suzuka, K; Tanaka, N; Yamazawa, K | 1 |
Sun, ZJ; Wan, XR; Xiang, Y; Yang, XY | 1 |
Lurain, JR; Nejad, B | 1 |
Chen, L; Dong, RF; Liu, N; Wan, XR; Wu, Y; Xiang, Y; Yang, XY | 1 |
Chan, KK; Lam, KW; Ngan, HY; Tam, KF | 1 |
Wan, X; Xiang, Y; Yang, J; Yang, X | 1 |
Lurain, JR; Schink, JC; Singh, DK | 2 |
Cagayan, MS; Lu-Lasala, LR | 1 |
Clarke-Pearson, DL; Kirkpatrick, JP; Sampson, JH; Soper, JT; Spillman, M; Wolf, JK | 1 |
Lv, W; Mao, Y; Wan, X; Xie, X | 1 |
El-Helw, LM; Hancock, BW | 1 |
Chen, L; Dong, R; Liu, N; Wan, X; Wu, Y; Xiang, Y; Yang, X | 1 |
Jiang, J; Kong, BH; Nan, FF; Wang, B; Yang, XS; Zhang, YZ | 1 |
Ashrafgangooei, T; Azamolsadat, M; Behroozi, S; Behtash, N; Fatemeh, G; Ghaemmaghami, F; Ghanbari, Z; Gilani, MM; Mitra, MG; Mousavi, A; Nadereh, B; Shohreh, B; Tahereh, A; Zinat, G | 1 |
Lindsay, I; Newlands, ES; Savage, PM; Schmid, P; Sebire, NJ; Seckl, MJ; Short, D; Wang, J | 1 |
Holden, L; McNeish, I; Newlands, ES; Rustin, GJ; Seckl, MJ; Strickland, S | 1 |
7 review(s) available for etoposide and Gestational Trophoblastic Neoplasia
Article | Year |
---|---|
Leptomeningeal disease as a presenting feature of gestational trophoblastic neoplasia: A review and recommendations for management.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cyclophosphamide; Dactinomycin; Etoposide; Female; Gestational Trophoblastic Disease; Humans; Methotrexate; Paclitaxel; Placenta; Pregnancy; Quality of Life; Retrospective Studies; Vincristine | 2023 |
Review of current literature on gestational trophoblastic neoplasia.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Dactinomycin; Etoposide; Female; Gestational Trophoblastic Disease; Humans; Methotrexate; Pregnancy; Retrospective Studies; Vincristine | 2023 |
Multiple metastatic gestational trophoblastic disease after a twin pregnancy with complete hydatidiform mole and coexisting fetus, following assisted reproductive technology: Case report and literature review.
Topics: Abortion, Induced; Adult; Antineoplastic Combined Chemotherapy Protocols; Chorionic Gonadotropin, beta Subunit, Human; Cyclophosphamide; Dactinomycin; Etoposide; Female; Fertilization in Vitro; Gestational Age; Gestational Trophoblastic Disease; Humans; Hydatidiform Mole; Hysterectomy; Lung Neoplasms; Methotrexate; Pregnancy; Pregnancy Complications, Neoplastic; Pregnancy, Twin; Tomography, X-Ray Computed; Uterine Hemorrhage; Uterine Neoplasms; Vincristine | 2018 |
Reproductive outcomes after hydatiform mole and gestational trophoblastic neoplasia.
Topics: Antineoplastic Agents; Etoposide; Female; Gestational Trophoblastic Disease; Humans; Hydatidiform Mole; Incidence; Leukemia, Myeloid; Menopause, Premature; Neoplasm Recurrence, Local; Neoplasms, Second Primary; Pregnancy; Pregnancy Outcome; Pregnancy Rate; Stillbirth; Uterine Neoplasms | 2015 |
Experience with platinum-based and high-dose chemotherapy in patients with gestational trophoblastic disease: possible implications for future management.
Topics: Adult; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Drug Administration Schedule; Etoposide; Female; Gestational Trophoblastic Disease; Humans; Leukemia; Pregnancy; Uterine Neoplasms | 2004 |
Secondary chemotherapy for high-risk gestational trophoblastic neoplasia.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cyclophosphamide; Dactinomycin; Etoposide; Female; Gestational Trophoblastic Disease; Humans; Methotrexate; Pregnancy; Treatment Outcome; Vincristine | 2005 |
Treatment of metastatic gestational trophoblastic neoplasia.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Dactinomycin; Etoposide; Female; Gestational Trophoblastic Disease; Humans; Methotrexate; Pregnancy; Vincristine | 2007 |
8 trial(s) available for etoposide and Gestational Trophoblastic Neoplasia
Article | Year |
---|---|
Efficacies of FAEV and EMA/CO regimens as primary treatment for gestational trophoblastic neoplasia.
Topics: Antineoplastic Combined Chemotherapy Protocols; Dactinomycin; Etoposide; Female; Floxuridine; Gestational Trophoblastic Disease; Humans; Neoplasm Recurrence, Local; Pregnancy; Vincristine | 2022 |
The efficacy and toxicity of 4-day chemotherapy with methotrexate, etoposide and actinomycin D in patients with choriocarcinoma and high-risk gestational trophoblastic neoplasia.
Topics: Adolescent; Adult; Aged; Anemia; Antineoplastic Combined Chemotherapy Protocols; Choriocarcinoma; Dactinomycin; Etoposide; Female; Gestational Trophoblastic Disease; Humans; Leukopenia; Menstrual Cycle; Methotrexate; Middle Aged; Nausea; Pregnancy; Retrospective Studies; Treatment Outcome; Uterine Neoplasms; Young Adult | 2020 |
Treatment of high-risk gestational trophoblastic neoplasia with etoposide, methotrexate, actinomycin D, cyclophosphamide, and vincristine chemotherapy.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Dactinomycin; Drug Administration Schedule; Etoposide; Female; Gestational Trophoblastic Disease; Humans; Methotrexate; Middle Aged; Prospective Studies; Risk Factors; Vincristine | 2003 |
Salvage chemotherapy for high-risk gestational trophoblastic tumor.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Dactinomycin; Etoposide; Female; Gestational Trophoblastic Disease; Humans; Leucovorin; Methotrexate; Middle Aged; Risk Factors; Salvage Therapy; Treatment Outcome | 2004 |
EMA/EP chemotherapy for chemorefractory gestational trophoblastic tumor.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Choriocarcinoma; Cisplatin; Dactinomycin; Drug Resistance, Neoplasm; Etoposide; Female; Gestational Trophoblastic Disease; Humans; Methotrexate; Middle Aged; Treatment Outcome | 2004 |
Relapse rate of patients with low-risk gestational trophoblastic tumor initially treated with single-agent chemotherapy.
Topics: Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Dactinomycin; Drug Resistance, Neoplasm; Etoposide; Female; Gestational Trophoblastic Disease; Humans; Infusions, Intravenous; Injections, Intramuscular; Leucovorin; Methotrexate; Recurrence; Remission Induction; Risk Factors; Treatment Outcome | 2005 |
Relapsed or refractory gestational trophoblastic neoplasia treated with the etoposide and cisplatin/etoposide, methotrexate, and actinomycin D (EP-EMA) regimen.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Diseases; Chemical and Drug Induced Liver Injury; Cisplatin; Cyclophosphamide; Dactinomycin; Dose-Response Relationship, Drug; Etoposide; Female; Follow-Up Studies; Gestational Trophoblastic Disease; Humans; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Pregnancy; Pregnancy Outcome; Remission Induction; Retrospective Studies; Salvage Therapy; Treatment Outcome; Vincristine | 2007 |
Efficacy of the FAEV regimen in the treatment of high-risk, drug-resistant gestational trophoblastic tumor.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Chorionic Gonadotropin; Dactinomycin; Drug Resistance, Neoplasm; Etoposide; Female; Floxuridine; Follow-Up Studies; Gestational Trophoblastic Disease; Humans; Middle Aged; Pregnancy; Treatment Outcome; Vincristine | 2007 |
83 other study(ies) available for etoposide and Gestational Trophoblastic Neoplasia
Article | Year |
---|---|
A Rare Case of Combined Choriocarcinoma and Placental Site Trophoblastic Tumor Presenting as Skin Lesion: A Case Report.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Choriocarcinoma; Cyclophosphamide; Etoposide; Female; Gestational Trophoblastic Disease; Humans; Methotrexate; Pain; Placenta; Pregnancy; Trophoblastic Tumor, Placental Site; Uterine Neoplasms; Vincristine | 2022 |
EMACO for treatment of gestational trophoblastic neoplasia: A multinational multicenter study.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Dactinomycin; Drug Resistance, Neoplasm; Etoposide; Female; Gestational Trophoblastic Disease; Humans; Methotrexate; Neoplasm Recurrence, Local; Pregnancy; Retrospective Studies; Vincristine | 2023 |
The first-line therapy for low-risk gestational trophoblastic neoplasia: Does single agent or multi-agent work?
Topics: Antineoplastic Combined Chemotherapy Protocols; Etoposide; Female; Gestational Trophoblastic Disease; Humans; Mitoxantrone; Prednimustine; Pregnancy | 2019 |
The use of VMP regimen as the first line chemotherapy for low-risk gestational trophoblastic neoplasia.
Topics: Antineoplastic Combined Chemotherapy Protocols; Etoposide; Female; Gestational Trophoblastic Disease; Humans; Mitoxantrone; Prednimustine; Pregnancy | 2019 |
EMA vs EMACO in the treatment of gestational trophoblastic neoplasia.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Dactinomycin; Doxorubicin; Etoposide; Female; Gestational Trophoblastic Disease; Humans; Leucovorin; Methotrexate; Mitoxantrone; Multivariate Analysis; Neoplasm Staging; Pregnancy; Retrospective Studies; Vincristine | 2020 |
Epithelioid trophoblastic tumor that requires fertility preservation: A case report and review of literature.
Topics: Antineoplastic Combined Chemotherapy Protocols; Chorionic Gonadotropin, beta Subunit, Human; Cisplatin; Etoposide; Female; Fertility Preservation; Gestational Trophoblastic Disease; Humans; Hysteroscopy; Pregnancy; Uterine Neoplasms; Young Adult | 2020 |
M-EA (methotrexate, etoposide, dactinomycin) and EMA-CO (methotrexate, etoposide, dactinomycin / cyclophosphamide, vincristine) regimens as first-line treatment of high-risk gestational trophoblastic neoplasia.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Dactinomycin; Etoposide; Female; Gestational Trophoblastic Disease; Humans; Methotrexate; Pregnancy; Risk Factors; Vincristine | 2021 |
Management and prognostic analysis of patients with gestational trophoblastic neoplasia (GTN) in FIGO stage IV and its special type.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cyclophosphamide; Dactinomycin; Disease Management; Etoposide; Female; Follow-Up Studies; Gestational Trophoblastic Disease; Humans; Methotrexate; Middle Aged; Neoplasm Staging; Pregnancy; Retrospective Studies; Survival Rate; Vincristine | 2021 |
Uterine Rescue in High-Risk Gestational Trophoblastic Neoplasia Treated with EMA-CO by Uterine Arteries Embolization due to Arteriovenous Malformations.
Topics: Antineoplastic Combined Chemotherapy Protocols; Arteriovenous Malformations; Cyclophosphamide; Dactinomycin; Embolization, Therapeutic; Etoposide; Female; Gestational Trophoblastic Disease; Humans; Methotrexate; Pregnancy; Pregnancy, High-Risk; Ultrasonography, Prenatal; Uterine Artery; Uterine Hemorrhage; Vincristine; Young Adult | 2021 |
Gestational trophoblastic neoplasia after human chorionic gonadotropin normalization in a retrospective cohort of 7761 patients in France.
Topics: Adolescent; Adult; Aftercare; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cell Transformation, Neoplastic; Choriocarcinoma; Chorionic Gonadotropin; Cisplatin; Cyclophosphamide; Dactinomycin; Etoposide; Female; France; Gestational Trophoblastic Disease; Humans; Hydatidiform Mole; Hysterectomy; Leucovorin; Methotrexate; Middle Aged; Neoplasm Staging; Pregnancy; Retrospective Studies; Trophoblastic Tumor, Placental Site; Uterine Neoplasms; Vincristine; Young Adult | 2021 |
Real-World Study of Cisplatin, Etoposide, and Bleomycin Chemotherapy Regimen in Gestational Trophoblastic Neoplasia.
Topics: Adult; Antineoplastic Agents; Bleomycin; Cisplatin; Disease-Free Survival; Drug Resistance, Neoplasm; Etoposide; Female; Follow-Up Studies; Gestational Trophoblastic Disease; Humans; Male; Middle Aged; Neoplasm Metastasis; Pregnancy; Pregnancy Complications; Prognosis; Prospective Studies; Radiotherapy; Remission Induction; Retrospective Studies; Salvage Therapy; Treatment Outcome | 2021 |
Results with Floxuridine, Actinomycin D, Etoposide, and Vincristine in Gestational Trophoblastic Neoplasias with International Federation of Gynecology and Obstetrics Scores ≥5.
Topics: Dactinomycin; Etoposide; Female; Floxuridine; Gestational Trophoblastic Disease; Humans; Obstetrics; Pregnancy; Vincristine | 2021 |
The added value of hysterectomy in the management of gestational trophoblastic neoplasia.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Chorionic Gonadotropin; Cohort Studies; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Drug Resistance, Neoplasm; Etoposide; Female; Gestational Trophoblastic Disease; Humans; Hysterectomy; Methotrexate; Middle Aged; Pregnancy; Retrospective Studies; Treatment Outcome; Vincristine; Young Adult | 2017 |
Clinical characteristics and prognosis of ultra high-risk gestational trophoblastic neoplasia patients: A retrospective cohort study.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Cohort Studies; Dactinomycin; Etoposide; Female; Floxuridine; Gestational Trophoblastic Disease; Humans; Middle Aged; Pregnancy; Prognosis; Retrospective Studies; Risk Factors; Salvage Therapy; Vincristine; Young Adult | 2017 |
Salvage chemotherapy for gestational trophoblastic neoplasia: Utility or futility?
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Dactinomycin; Disease-Free Survival; Etoposide; Female; Gestational Trophoblastic Disease; Humans; Kaplan-Meier Estimate; Medical Futility; Methotrexate; Middle Aged; Pregnancy; Retrospective Studies; Risk Factors; Salvage Therapy; Vincristine; Young Adult | 2017 |
Reproductive Outcomes After Gestational Trophoblastic Neoplasia. A Comparison Between Single-Agent and Multiagent Chemotherapy: Retrospective Analysis From the MITO-9 Group.
Topics: Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Clinical Trials as Topic; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Etoposide; Female; Gestational Trophoblastic Disease; Humans; Hysterectomy; Infant, Newborn; Italy; Male; Methotrexate; Multicenter Studies as Topic; Pregnancy; Pregnancy Outcome; Retrospective Studies; Vincristine; Young Adult | 2018 |
Surgery and Platinum/Etoposide-Based Chemotherapy for the Treatment of Epithelioid Trophoblastic Tumor.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Etoposide; Female; Gestational Trophoblastic Disease; Humans; Lung Neoplasms; Organoplatinum Compounds; Pregnancy; Retrospective Studies | 2018 |
Treatment results of the second-line chemotherapy regimen for patients with low-risk gestational trophoblastic neoplasia treated with 5-day methotrexate and 5-day etoposide.
Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Drug Administration Schedule; Drug Resistance, Neoplasm; Etoposide; Female; Gestational Trophoblastic Disease; Humans; Japan; Methotrexate; Neoplasm Recurrence, Local; Pregnancy; Remission Induction; Retrospective Studies; Risk Factors; Treatment Outcome | 2018 |
[Curative effects and influenced factors of EMA-CO as an initial regimen for the treatment of high-risk gestational trophoblastic neoplasia].
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Etoposide; Female; Gestational Trophoblastic Disease; Humans; Methotrexate; Pregnancy; Prognosis; Remission Induction; Retrospective Studies; Salvage Therapy; Vincristine | 2018 |
Is there uniformity in definitions and treatment of gestational trophoblastic disease in Europe?
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Dactinomycin; Etoposide; Europe; Female; Gestational Trophoblastic Disease; Humans; Methotrexate; Neoplasm Recurrence, Local; Pregnancy; Prognosis; Vincristine | 2019 |
Can carboplatin or etoposide replace actinomycin-d for second-line treatment of methotrexate resistant low-risk gestational trophoblastic neoplasia?
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Brazil; Carboplatin; Dactinomycin; Drug Resistance, Neoplasm; Drug Substitution; Etoposide; Female; Gestational Trophoblastic Disease; Humans; Methotrexate; Pregnancy; Retrospective Studies; Treatment Outcome; Young Adult | 2019 |
High-dose chemotherapy with autologous stem cell support as salvage therapy in recurrent gestational trophoblastic disease.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Etoposide; Female; Gestational Trophoblastic Disease; Humans; Methotrexate; Neoplasm Recurrence, Local; Pregnancy; Prognosis; Remission Induction; Salvage Therapy; Stem Cell Transplantation; Transplantation, Autologous; Vincristine | 2013 |
Outcome of gestational trophoblastic neoplasia: experience from a tertiary cancer centre in India.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Choriocarcinoma; Cyclophosphamide; Dactinomycin; Etoposide; Female; Gestational Trophoblastic Disease; Humans; India; Methotrexate; Middle Aged; Pregnancy; Salvage Therapy; Survival Analysis; Tertiary Care Centers; Treatment Outcome; Vincristine; Young Adult | 2014 |
Actinomycin D, cisplatin, and etoposide regimen is associated with almost universal cure in patients with high-risk gestational trophoblastic neoplasia.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Dactinomycin; Etoposide; Female; Gestational Trophoblastic Disease; Humans; Middle Aged; Pregnancy; Remission Induction; Survival Analysis; Young Adult | 2014 |
Combination chemotherapy regimen with floxuridine, dactinomycin, etoposide, and vincristine as primary treatment for gestational trophoblastic neoplasia.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Dactinomycin; Etoposide; Female; Floxuridine; Gestational Trophoblastic Disease; Humans; Middle Aged; Pregnancy; Retrospective Studies; Treatment Outcome; Vincristine; Young Adult | 2014 |
Gestational trophoblastic neoplasia: treatment outcomes from a single institutional experience.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Brain Neoplasms; Choriocarcinoma; Cisplatin; Cyclophosphamide; Dactinomycin; Etoposide; Female; Gestational Trophoblastic Disease; Humans; Hysterectomy; Liver Neoplasms; Lung Neoplasms; Methotrexate; Middle Aged; Neoplasm Staging; Pregnancy; Remission Induction; Retrospective Studies; Risk Factors; Salvage Therapy; Survival Rate; Uterine Neoplasms; Vaginal Neoplasms; Vincristine; Young Adult | 2015 |
Resistance to single-agent chemotherapy and its risk factors in low-risk gestational trophoblastic neoplasms.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Case-Control Studies; Cyclophosphamide; Dactinomycin; Drug Resistance, Neoplasm; Etoposide; Female; Gestational Trophoblastic Disease; Humans; Iran; Methotrexate; Middle Aged; Pregnancy; Risk Factors; Vincristine; Young Adult | 2015 |
Effects of single-agent and combination chemotherapy for gestational trophoblastic tumors on risks of second malignancy and early menopause.
Topics: Adolescent; Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Child; Cohort Studies; Cyclophosphamide; Dactinomycin; Etoposide; Female; Follow-Up Studies; Gestational Trophoblastic Disease; Humans; Incidence; Kaplan-Meier Estimate; Menopause, Premature; Methotrexate; Middle Aged; Neoplasms, Second Primary; Odds Ratio; Pregnancy; Risk Assessment; Risk Factors; Uterine Neoplasms; Vincristine; Young Adult | 2015 |
Brain metastases in gestational trophoblast neoplasia: an update on incidence, management and outcome.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Choriocarcinoma, Non-gestational; Cisplatin; Cohort Studies; Cyclophosphamide; Dactinomycin; Etoposide; Female; Gestational Trophoblastic Disease; Humans; Hydatidiform Mole; Methotrexate; Middle Aged; Pregnancy; Treatment Outcome; Vincristine; Young Adult | 2015 |
Response to chemotherapy in overweight/obese patients with low-risk gestational trophoblastic neoplasia.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Chorionic Gonadotropin, beta Subunit, Human; Cohort Studies; Cyclophosphamide; Dactinomycin; Etoposide; Female; Gestational Trophoblastic Disease; Humans; Methotrexate; Middle Aged; Neoplasm Staging; Obesity; Overweight; Pregnancy; Prognosis; Remission Induction; Vincristine; Young Adult | 2015 |
Management and prognosis of patients with brain metastasis from gestational trophoblastic neoplasia: a 24-year experience in Peking union medical college hospital.
Topics: Adult; Brain Neoplasms; China; Combined Modality Therapy; Dactinomycin; Disease-Free Survival; Drug Resistance, Neoplasm; Etoposide; Female; Floxuridine; Gestational Trophoblastic Disease; Humans; Middle Aged; Pregnancy; Pregnancy Complications, Neoplastic; Prognosis; Risk Factors; Vincristine | 2015 |
Relationship between race and clinical characteristics, extent of disease, and response to chemotherapy in patients with low-risk gestational trophoblastic neoplasia.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Asian; Black or African American; Chorionic Gonadotropin; Cyclophosphamide; Dactinomycin; Etoposide; Female; Folic Acid; Gestational Trophoblastic Disease; Humans; Methotrexate; Middle Aged; Neoplasm Staging; Pregnancy; Risk Factors; White People; Young Adult | 2015 |
A 30-year experience in using oral methotrexate as initial treatment for gestational trophoblastic neoplasia regardless of risk group.
Topics: Administration, Oral; Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Chorionic Gonadotropin; Cyclophosphamide; Dactinomycin; Etoposide; Female; Follow-Up Studies; Gestational Trophoblastic Disease; Humans; Methotrexate; Middle Aged; Pregnancy; Risk Factors; Treatment Outcome; Vincristine; Young Adult | 2016 |
Human Chorionic Gonadotropin (hCG) Regression Curve for Predicting Response to EMA/CO (Etoposide, Methotrexate, Actinomycin D, Cyclophosphamide and Vincristine) Regimen in Gestational Trophoblastic Neoplasia.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Child; Chorionic Gonadotropin; Cyclophosphamide; Dactinomycin; Drug Resistance, Neoplasm; Etoposide; Female; Follow-Up Studies; Gestational Trophoblastic Disease; Humans; Methotrexate; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Nomograms; Pregnancy; Prognosis; Regression Analysis; ROC Curve; Vincristine; Young Adult | 2015 |
The Role of Computed Tomography Scanning of the Thorax in the Initial Assessment of Gestational Trophoblastic Neoplasia.
Topics: Administration, Intravenous; Adult; Antineoplastic Combined Chemotherapy Protocols; Chorionic Gonadotropin; Dactinomycin; Etoposide; Female; Gestational Trophoblastic Disease; Humans; Lung Neoplasms; Methotrexate; Neoplasm Staging; Pregnancy; Radiography, Thoracic; Risk Assessment; Salvage Therapy; Tomography, X-Ray Computed | 2015 |
Mortality rate of gestational trophoblastic neoplasia with a FIGO score of ≥13.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Child; Cisplatin; Etoposide; Female; France; Gestational Trophoblastic Disease; Humans; Kaplan-Meier Estimate; Liver Neoplasms; Middle Aged; Mortality; Pregnancy; Prognosis; Retrospective Studies; Risk Factors; Severity of Illness Index; Time Factors; Young Adult | 2016 |
BEP for high-risk gestational trophoblastic tumor: results from a cohort of 45 patients.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Cohort Studies; Etoposide; Female; Follow-Up Studies; Gestational Trophoblastic Disease; Humans; Middle Aged; Pregnancy | 2015 |
Conservative Chemotherapy in Gestational Trophoblastic Disease: Experience With Etoposide, Methotrexate, and Dactinomycin Chemotherapy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Dactinomycin; Drug Resistance, Neoplasm; Etoposide; Female; Follow-Up Studies; Gestational Trophoblastic Disease; Humans; Methotrexate; Neoplasm Invasiveness; Neoplasm Staging; Pregnancy; Prognosis; Salvage Therapy | 2016 |
Etoposide-Actinomycin as Salvage Regimen for the Treatment of Nonmetastatic and Low-Risk Metastatic Gestational Trophoblastic Neoplasia: Experience at the Philippine General Hospital.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Dactinomycin; Etoposide; Female; Gestational Trophoblastic Disease; Humans; Pregnancy; Retrospective Studies; Risk Factors; Salvage Therapy | 2016 |
Prognosis of Patients with Gestational Trophoblastic Neoplasia and Obstetric Outcomes of Those Conceiving After Chemotherapy.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Chorionic Gonadotropin, beta Subunit, Human; Dactinomycin; Etoposide; Female; Fertility Preservation; Gestational Trophoblastic Disease; Humans; Leucovorin; Methotrexate; Middle Aged; Pregnancy; Prognosis; Term Birth; Treatment Outcome; Uterine Neoplasms; Young Adult | 2016 |
Primary treatment of stage IV gestational trophoblastic neoplasia with floxuridine, dactinomycin, etoposide and vincristine (FAEV): A report based on our 10-year clinical experiences.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Dactinomycin; Etoposide; Female; Floxuridine; Gestational Trophoblastic Disease; Humans; Neoplasm Staging; Pregnancy; Vincristine | 2016 |
Is chemotherapy necessary for patients with molar pregnancy and human chorionic gonadotropin serum levels raised but falling at 6months after uterine evacuation?
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Brazil; Case-Control Studies; Chemotherapy, Adjuvant; Chorionic Gonadotropin; Cohort Studies; Cyclophosphamide; Dactinomycin; Etoposide; Female; Gestational Trophoblastic Disease; Humans; Hydatidiform Mole; Leucovorin; Methotrexate; Middle Aged; Neoplasm Staging; Pregnancy; Retrospective Studies; Treatment Outcome; Uterine Neoplasms; Vacuum Curettage; Vincristine; Watchful Waiting; Young Adult | 2016 |
Diagnosis and treatment of high-risk metastatic gestational trophoblastic neoplasia in Hungary.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carboplatin; Cisplatin; Cyclophosphamide; Dactinomycin; Etoposide; Female; Gestational Trophoblastic Disease; Humans; Hungary; Hysterectomy; Methotrexate; Middle Aged; Pregnancy; Risk Factors; Vincristine; Young Adult | 2008 |
Gestational trophoblastic tumor with liver metastasis after misoprostol abortion.
Topics: Abortifacient Agents, Nonsteroidal; Abortion, Induced; Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Dactinomycin; Etoposide; Female; Gestational Trophoblastic Disease; Humans; Liver Neoplasms; Methotrexate; Misoprostol; Pregnancy; Uterine Neoplasms; Vincristine | 2009 |
[Efficacy of surgical management combined with chemotherapy in the treatment of drug-resistant gestational trophoblastic neoplasm].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Chorionic Gonadotropin, beta Subunit, Human; Combined Modality Therapy; Dactinomycin; Drug Resistance, Neoplasm; Etoposide; Female; Fluorouracil; Gestational Trophoblastic Disease; Humans; Hysterectomy; Lung Neoplasms; Middle Aged; Neoplasm Staging; Pregnancy; Retrospective Studies; Treatment Outcome; Uterine Neoplasms; Young Adult | 2008 |
Maternal and perinatal outcomes of first pregnancy after chemotherapy for gestational trophoblastic neoplasia in Brazilian women.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brazil; Cisplatin; Cohort Studies; Cyclophosphamide; Dactinomycin; Doxorubicin; Etoposide; Female; Gestational Trophoblastic Disease; Humans; Hydroxyurea; Methotrexate; Pregnancy; Pregnancy Outcome; Retrospective Studies; Risk Factors; Vincristine | 2009 |
[Pulmonary resection in the management of gestational trophoblastic neoplasia: a clinical study].
Topics: Antineoplastic Combined Chemotherapy Protocols; Chorionic Gonadotropin, beta Subunit, Human; Combined Modality Therapy; Etoposide; Female; Follow-Up Studies; Gestational Trophoblastic Disease; Humans; Lung Neoplasms; Methotrexate; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Pneumonectomy; Pregnancy; Prognosis; Retrospective Studies | 2008 |
Balloon tamponade of hemorrhage after uterine curettage for gestational trophoblastic disease.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Balloon Occlusion; Catheterization; Dactinomycin; Dilatation and Curettage; Etoposide; Female; Gestational Trophoblastic Disease; Humans; Leucovorin; Lung Neoplasms; Methotrexate; Pregnancy; Uterine Hemorrhage | 2009 |
Surgical resection in the management of pulmonary metastatic disease of gestational trophoblastic neoplasia.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Dactinomycin; Drug Resistance, Neoplasm; Etoposide; Female; Fluorouracil; Gestational Trophoblastic Disease; Humans; Lung Neoplasms; Methotrexate; Middle Aged; Neoplasm Staging; Pregnancy; Vincristine; Young Adult | 2009 |
Metastasis of gestational trophoblastic neoplasia to the spinal canal: a case report.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Chorionic Gonadotropin, beta Subunit, Human; Dactinomycin; Etoposide; Female; Floxuridine; Gestational Trophoblastic Disease; Humans; Magnetic Resonance Imaging; Methotrexate; Pregnancy; Spinal Canal; Spinal Neoplasms; Uterine Neoplasms; Vincristine; Young Adult | 2009 |
A case of uterine pseudoaneurysm combined with gestational trophoblastic disease in a 30-year-old woman.
Topics: Adult; Aneurysm, False; Antineoplastic Combined Chemotherapy Protocols; Chorionic Gonadotropin, beta Subunit, Human; Cyclophosphamide; Dactinomycin; Dilatation and Curettage; Etoposide; Female; Gestational Trophoblastic Disease; Humans; Methotrexate; Trophoblastic Neoplasms; Ultrasonography, Doppler; Uterine Artery; Uterine Artery Embolization; Vincristine | 2011 |
Gestational trophoblastic neoplasia with retroperitoneal metastases: a fatal complication.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Etoposide; Fatal Outcome; Female; Gestational Trophoblastic Disease; Humans; Pregnancy; Pregnancy Complications, Neoplastic; Retroperitoneal Neoplasms | 2010 |
[Clinical analysis of patients with relapsed and chemo-resistant gestational trophoblastic neoplasia].
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Chorionic Gonadotropin, beta Subunit, Human; Cisplatin; Drug Resistance, Neoplasm; Etoposide; Female; Gestational Trophoblastic Disease; Humans; Lung Neoplasms; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Pregnancy; Prognosis; Retrospective Studies; Time Factors; Treatment Outcome; Vincristine; Young Adult | 2010 |
Salvage combination chemotherapy with floxuridine, dactinomycin, etoposide, and vincristine (FAEV) for patients with relapsed/chemoresistant gestational trophoblastic neoplasia.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Dactinomycin; Drug Resistance, Neoplasm; Etoposide; Female; Floxuridine; Follow-Up Studies; Gestational Trophoblastic Disease; Humans; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Maximum Tolerated Dose; Middle Aged; Neoplasm Recurrence, Local; Pregnancy; Pregnancy Complications, Neoplastic; Remission Induction; Retrospective Studies; Salvage Therapy; Survival Rate; Treatment Outcome; Vincristine; Young Adult | 2011 |
Characterisation of transient benign hCG elevations in women following chemotherapy for GTT.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chorionic Gonadotropin; Cisplatin; Cyclophosphamide; Dactinomycin; Estradiol; Etoposide; Female; Follicle Stimulating Hormone; Gestational Trophoblastic Disease; Humans; Ifosfamide; Leucovorin; Luteinizing Hormone; Methotrexate; Pregnancy; Retrospective Studies; Taxoids; Vincristine; Young Adult | 2011 |
Etoposide, cisplatin-etoposide, methotrexate, actinomycin-D as primary treatment for management of very-high-risk gestational trophoblastic neoplasia.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Dactinomycin; Disease Progression; Etoposide; Female; Gestational Trophoblastic Disease; Humans; India; Liver Neoplasms; Methotrexate; Middle Aged; Pregnancy; Retrospective Studies; Risk; Salvage Therapy; Survival Rate; Treatment Outcome; Young Adult | 2011 |
Minimally-aggressive gestational trophoblastic neoplasms.
Topics: Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Chorionic Gonadotropin; Cisplatin; Cyclophosphamide; Dactinomycin; Etoposide; Female; Gestational Trophoblastic Disease; Humans; Methotrexate; Middle Aged; Pregnancy; Treatment Outcome; Vincristine | 2012 |
The roles of surgery and EMA/CO chemotherapy regimen in primary refractory and non-refractory gestational trophoblastic neoplasia.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Chorionic Gonadotropin; Cyclophosphamide; Dactinomycin; Etoposide; Female; Follow-Up Studies; Gestational Trophoblastic Disease; Half-Life; Humans; Methotrexate; Middle Aged; Pregnancy; Retrospective Studies; Uterine Neoplasms; Vincristine; Young Adult | 2012 |
EP-EMA regimen (etoposide and cisplatin with etoposide, methotrexate, and dactinomycin) in a series of 18 women with gestational trophoblastic neoplasia.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Dactinomycin; Etoposide; Female; Follow-Up Studies; Gestational Trophoblastic Disease; Humans; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Pregnancy; Prognosis; Retrospective Studies; Uterine Neoplasms; Young Adult | 2012 |
Treatment of high-risk gestational trophoblastic neoplasia with weekly high-dose methotrexate-etoposide.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Dose-Response Relationship, Drug; Etoposide; Female; Gestational Trophoblastic Disease; Humans; Methotrexate; Pregnancy; Retrospective Studies | 2012 |
Human chorionic gonadotropin (hCG) regression normograms for patients with high-risk gestational trophoblastic neoplasia treated with EMA/CO (etoposide, methotrexate, actinomycin D, cyclophosphamide and vincristine) chemotherapy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Chorionic Gonadotropin; Cyclophosphamide; Dactinomycin; Drug Resistance, Neoplasm; Etoposide; Female; Gestational Trophoblastic Disease; Humans; Methotrexate; Middle Aged; Neoplasm Metastasis; Pregnancy; Vincristine | 2012 |
Comparison of methotrexate, actinomycin D, and etoposide for treating low-risk gestational trophoblastic neoplasia.
Topics: Adult; Alopecia; Antineoplastic Agents; Chorionic Gonadotropin; Dactinomycin; Etoposide; Female; Gestational Trophoblastic Disease; Humans; Leucovorin; Methotrexate; Nausea; Pregnancy; Prospective Studies; Remission Induction; Stomatitis; Vitamin B Complex; Vomiting; Young Adult | 2012 |
Fatal cases of gestational trophoblastic neoplasia over four decades in the Netherlands: a retrospective cohort study.
Topics: Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cause of Death; Choriocarcinoma; Cohort Studies; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Etoposide; Female; Gestational Trophoblastic Disease; Guideline Adherence; Humans; Hydatidiform Mole; Hysterectomy; Methotrexate; Middle Aged; Neoplasm Metastasis; Netherlands; Practice Guidelines as Topic; Pregnancy; Retrospective Studies; Risk Assessment; Treatment Outcome; Uterine Neoplasms; Vincristine | 2012 |
Comparing cisplatin-based combination chemotherapy with EMA/CO chemotherapy for the treatment of high risk gestational trophoblastic neoplasia.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chorionic Gonadotropin; Cisplatin; Cyclophosphamide; Dactinomycin; Etoposide; Female; Follow-Up Studies; Gestational Trophoblastic Disease; Humans; Methotrexate; Middle Aged; Netherlands; Pregnancy; Prognosis; Remission Induction; Risk Factors; Survival Rate; Vincristine | 2013 |
[Therapeutic evaluation of cisplatin, etoposide, and bleomycin chemotherapy regimen in high-risk gestational trophoblastic neoplasia].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chorionic Gonadotropin, beta Subunit, Human; Cisplatin; Cyclophosphamide; Etoposide; Female; Gestational Trophoblastic Disease; Humans; Middle Aged; Neoplasm Staging; Pregnancy; Prognosis; Retrospective Studies; Treatment Outcome; Uterine Neoplasms; Young Adult | 2012 |
EMA/CO for high-risk gestational trophoblastic neoplasia: good outcomes with induction low-dose etoposide-cisplatin and genetic analysis.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cohort Studies; Cyclophosphamide; Dactinomycin; Drug Resistance, Neoplasm; Etoposide; Female; Gestational Trophoblastic Disease; Humans; Methotrexate; Pregnancy; Remission Induction; Retrospective Studies; Risk Factors; Survival Analysis; Treatment Outcome; Vincristine | 2013 |
Anti-Müllerian hormone as a marker of ovarian reserve following chemotherapy in patients with gestational trophoblastic neoplasia.
Topics: Adult; Anti-Mullerian Hormone; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Biomarkers; Dactinomycin; Dilatation and Curettage; Etoposide; Female; Follow-Up Studies; Gestational Trophoblastic Disease; Humans; Hydatidiform Mole; Methotrexate; Ovary; Pregnancy; Young Adult | 2013 |
Two cases of therapy-related acute promyelocytic leukemia (t-APL) after mantle cell lymphoma and gestational trophoblastic disease.
Topics: Adult; Aged; Antineoplastic Agents, Alkylating; Arsenic Trioxide; Arsenicals; Etoposide; Female; Gestational Trophoblastic Disease; Humans; Leukemia, Promyelocytic, Acute; Lymphoma, Mantle-Cell; Male; Neoplasms, Second Primary; Oxides; Pregnancy; Tretinoin | 2002 |
Risk of abnormal pregnancy completing chemotherapy for gestational trophoblastic tumor.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Dactinomycin; Etoposide; Female; Gestational Trophoblastic Disease; Humans; Methotrexate; Pregnancy; Pregnancy Outcome; Remission Induction; Time Factors | 2003 |
Management of patients with metastatic gestational trophoblastic tumor.
Topics: Adolescent; Adult; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cyclophosphamide; Dactinomycin; Etoposide; Female; Gestational Trophoblastic Disease; Humans; Methotrexate; Middle Aged; Pregnancy; Retrospective Studies; Risk Factors | 2004 |
Successful salvage of relapsed high-risk gestational trophoblastic neoplasia patients using a novel paclitaxel-containing doublet.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Choriocarcinoma; Cisplatin; Etoposide; Female; Gestational Trophoblastic Disease; Humans; Neoplasm Recurrence, Local; Paclitaxel; Pregnancy; Salvage Therapy; Uterine Neoplasms | 2004 |
[Etopside, methotrexate, kengshengmycin/etopside, cisplatin chemotherapy for chemorefractory gestational trophoblastic tumour].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Dactinomycin; Drug Administration Schedule; Drug Resistance, Neoplasm; Etoposide; Female; Gestational Trophoblastic Disease; Humans; Leukopenia; Methotrexate; Middle Aged; Neoplasm Staging; Pregnancy; Treatment Outcome; Trophoblastic Tumor, Placental Site; Uterine Neoplasms | 2005 |
[Efficacy of FAEV regimen in treatment of high-risk drug-resistant gestational trophoblastic tumor].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Chorionic Gonadotropin, beta Subunit, Human; Dactinomycin; Drug Resistance, Neoplasm; Etoposide; Female; Floxuridine; Follow-Up Studies; Gestational Trophoblastic Disease; Humans; Middle Aged; Neoplasm Staging; Pregnancy; Treatment Outcome; Vincristine | 2006 |
Methotrexate, bleomycin, and Etoposide in the treatment of gestational trophoblastic neoplasia.
Topics: Adult; Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Etoposide; Female; Follow-Up Studies; Gestational Trophoblastic Disease; Humans; Methotrexate; Pregnancy; Retrospective Studies; Survival Rate; Treatment Outcome; Uterine Neoplasms | 2006 |
Recurrent gestational trophoblastic tumor: management and risk factors for recurrence.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Chorionic Gonadotropin, beta Subunit, Human; Dactinomycin; Etoposide; Female; Fluorouracil; Gestational Trophoblastic Disease; Humans; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Pregnancy; Retrospective Studies; Risk Factors; Vincristine | 2006 |
Primary treatment of metastatic high-risk gestational trophoblastic neoplasia with EMA-CO chemotherapy.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Dactinomycin; Etoposide; Female; Gestational Trophoblastic Disease; Humans; Illinois; Medical Records; Methotrexate; Middle Aged; Neoplasm Metastasis; Pregnancy; Retrospective Studies; Survival Analysis; Treatment Outcome; Uterine Neoplasms; Vincristine | 2006 |
Role of surgery in the management of high-risk gestational trophoblastic neoplasia.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Etoposide; Female; Gestational Trophoblastic Disease; Humans; Hysterectomy; Illinois; Medical Records; Methotrexate; Middle Aged; Pregnancy; Retrospective Studies; Survival Analysis; Uterine Neoplasms; Vincristine | 2006 |
Management of gestational trophoblastic neoplasia with metastasis to the central nervous system: A 12-year review at the Philippine General Hospital.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Etoposide; Female; Gestational Trophoblastic Disease; Humans; Injections, Spinal; Medical Records; Methotrexate; Middle Aged; Neoplasm Metastasis; Philippines; Pregnancy; Retrospective Studies; Survival Analysis; Uterine Neoplasms; Vincristine | 2006 |
High-risk gestational trophoblastic neoplasia with brain metastases: individualized multidisciplinary therapy in the management of four patients.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Choriocarcinoma; Cisplatin; Craniotomy; Cyclophosphamide; Dactinomycin; Etoposide; Female; Folic Acid; Gestational Trophoblastic Disease; Humans; Methotrexate; Neoplasm Staging; Pregnancy; Radiosurgery; Risk Factors; Vincristine | 2007 |
[Combination chemotherapy with etoposide and cisplatin for high-risk, chemorefractory and recurrent gestational trophoblastic neoplasia].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Chorionic Gonadotropin; Cisplatin; Drug Resistance, Neoplasm; Etoposide; Female; Follow-Up Studies; Gestational Trophoblastic Disease; Humans; Leukopenia; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Pregnancy; Pregnancy Outcome; Retrospective Studies; Treatment Outcome; Uterine Neoplasms; Vomiting; Young Adult | 2007 |
Assessment of the response to chemotherapy in gestational trophoblastic neoplasia with vaginal metastases.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Cohort Studies; Cyclophosphamide; Dactinomycin; Etoposide; Female; Gestational Trophoblastic Disease; Humans; Methotrexate; Middle Aged; Neoplasm Staging; Pregnancy; Retrospective Studies; Survival Analysis; Vaginal Neoplasms; Vincristine; Young Adult | 2008 |
Salvage chemotherapy of relapsed or high-risk gestational trophoblastic neoplasia (GTN) with paclitaxel/cisplatin alternating with paclitaxel/etoposide (TP/TE).
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cohort Studies; Dose-Response Relationship, Drug; Drug Administration Schedule; Etoposide; Female; Follow-Up Studies; Gestational Trophoblastic Disease; Humans; Middle Aged; Neoplasm Recurrence, Local; Paclitaxel; Pregnancy; Pregnancy Complications, Neoplastic; Retrospective Studies; Risk Assessment; Salvage Therapy; Survival Analysis | 2008 |
Management of brain metastases in patients with high-risk gestational trophoblastic tumors.
Topics: Adult; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Cause of Death; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Etoposide; Female; Gestational Trophoblastic Disease; Humans; Methotrexate; Pregnancy; Pregnancy Outcome; Pregnancy, High-Risk; Prognosis; Remission Induction; Retrospective Studies; Risk Factors; Survival Analysis; Treatment Outcome; Vincristine | 2002 |